Document is current

Article History

Accepted: 2 December 2024

First Online: 16 January 2025

Declarations

:

: Open access funding was provided by LEO Pharma Inc.

: Joe Gorelick has had a financial agreement or affiliation with the following commercial interests as a consultant, speaker, or advisor: AbbVie Pharmaceuticals, Arcutis, Beiersdorf, Bristol Meyers Squib, Dermavant, Ferndale, Galderma, Incyte, Janssen, Lilly, LEO, Lyceum, Novartis Pharmaceuticals, Pfizer, Regeneron Pharmaceuticals, Sanofi Genzyme, Sun Pharma, and UCB. Andrea Nguyen has served as a speaker, investigator and/or consultant from AbbVie Pharmaceuticals, Almirall, Amgen, Arcutis, ASLAN, Beiersdorf, Boehringer Ingelheim, Bristol Meyers Squibb, Dermira, Dermavant, EPI, Galderma, Incyte, ISDIN, Janssen, Lilly, LEO, Mayne, Novan, Novartis Pharmaceuticals, Ortho Dermatologics, Pfizer, Regeneron Pharmaceuticals, Sanofi Genzyme, Sun Pharma, and UCB. April W. Armstrong has served as a consultant for and received honoraria from AbbVie, Almirall, Arcutis, ASLAN, Beiersdorf, BI, BMS, EPI, Incyte, LEO Pharma, UCB, Janssen, Lilly, Nimbus, Novartis, Ortho Dermatologics, Sun, Dermavant, Dermira, Sanofi, Regeneron, and Pfizer; she has participated on advisory boards for Boehringer Ingelheim and Parexel. Britta C. Martel and Daniel Madsen are employees and shareholders of LEO Pharma A/S. Shannon Schneider is an employee of LEO Pharma Inc.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: All authors contributed to the conceptualization, review, editing, and supervision of this manuscript. All authors read and approved the final manuscript.